Literature DB >> 25185628

Pelvic floor physical therapy: impact on quality of life 6 months after vaginal reconstructive surgery.

Rachel N Pauls1, Catrina C Crisp, Kathleen Novicki, Angela N Fellner, Steven D Kleeman.   

Abstract

OBJECTIVES: Pelvic floor physical therapy (PFPT) is often used as a treatment of pelvic floor disorders and may improve function after pelvic reconstructive surgery. However, the long-term impact of this modality is not understood.
METHODS: This randomized controlled trial compared PFPT to the standard care in women undergoing vaginal reconstruction. The intervention group received PFPT biweekly until 12 weeks postoperatively, in conjunction with a physician assessment. Control subjects underwent a physician assessment alone at all postoperative intervals. The final follow-up was at 24 weeks. Physical examinations (pelvic organ prolapse quantification assessment), intravaginal electromyography, voiding diaries, and validated questionnaires were completed by all subjects. The primary outcome was change in the World Health Organization Quality of Life-BREF.
RESULTS: Forty-nine women completed the study, 24 in the PFPT group and 25 in the control group. Although electromyography measures showed better muscular function in PFPT subjects after 12 weeks, at 6 months after surgery, this was no longer noted. However, quality of life parameters improved for the entire sample at 24 weeks, with no difference between groups. Positive change from 12 to 24 weeks was also documented in scores on the Pelvic Floor Distress Inventory-20 (P = 0.04) and Pelvic Floor Impact Questionnaire-7 (P = 0.018), corresponding with continued improvement in bladder symptoms. Finally, Prolapse and Incontinence Sexual Questionnaire-12 and Female Sexual Function Index scores improved between 12 and 24 weeks, suggesting better sexual function overall with time elapsed from surgery.
CONCLUSIONS: Quality of life improves in all subjects after vaginal reconstructive surgery, with ongoing benefit between 3 and 6 months. Nevertheless, standardized PFPT was not associated with differences at 24 weeks in this cohort of women.

Entities:  

Mesh:

Year:  2014        PMID: 25185628     DOI: 10.1097/SPV.0000000000000090

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  5 in total

1.  Building a Multidisciplinary Academic Surgical Gender-affirmation Program: Lessons Learned.

Authors:  Oscar J Manrique; Samyd S Bustos; Valeria P Bustos; Andres A Mascaro; Pedro Ciudad; Antonio J Forte; Gabriel Del Corral; Esther A Kim; Howard N Langstein
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-19

2.  A preliminary clinical report of transvaginal natural orifice transluminal endoscopic Sacrospinous Ligament Fixation in the treatment of moderate and severe pelvic organ prolapse.

Authors:  Zhenyue Qin; Zhiyong Dong; Huimin Tang; Shoufeng Zhang; Huihui Wang; Mingyue Bao; Weiwei Wei; Ruxia Shi; Jiming Chen; Bairong Xia
Journal:  Front Surg       Date:  2022-07-29

Review 3.  International urogynecology consultation chapter 3 committee 2; conservative treatment of patient with pelvic organ prolapse: Pelvic floor muscle training.

Authors:  Kari Bø; Sònia Anglès-Acedo; Achla Batra; Ingeborg Hoff Brækken; Yi Ling Chan; Cristine Homsi Jorge; Jennifer Kruger; Manisha Yadav; Chantale Dumoulin
Journal:  Int Urogynecol J       Date:  2022-08-18       Impact factor: 1.932

4.  Perioperative Behavioral Therapy and Pelvic Muscle Strengthening Do Not Enhance Quality of Life After Pelvic Surgery: Secondary Report of a Randomized Controlled Trial.

Authors:  Alison C Weidner; Matthew D Barber; Alayne Markland; David D Rahn; Yvonne Hsu; Elizabeth R Mueller; Sharon Jakus-Waldman; Keisha Y Dyer; Lauren Klein Warren; Marie G Gantz; Susie Meikle
Journal:  Phys Ther       Date:  2017-11-01

Review 5.  Is PREHAB in Pelvic Floor Surgery Needed? A Topical Review.

Authors:  Jacek K Szymański; Małgorzata Starzec-Proserpio; Aneta Słabuszewska-Jóźwiak; Grzegorz Jakiel
Journal:  Medicina (Kaunas)       Date:  2020-11-06       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.